Martin Fiennes

OSI JSC Member
Martin Fiennes is an experienced venture capital investor and a Principal at Oxford Sciences Innovation plc.  He is responsible for various OSI portfolio companies including Albus Health (asthma monitoring technology), Caristo Diagnostics (biomarker for cardio-vascular disease), and Oxsight (technology for people with low vision). He has been involved in early stage UK technology both as an investor and a corporate finance advisor since 1997. Martin is also a Non Executive Director at Kings Arms Yard VCT plc, and a Trustee of the HDH Wills 1965 Charitable Trust.

Steering Committee

Accepting applications
Ready to accelerate your digital idea from concept to innovation
Apply now